Loopdx

Barcelona, ES · 1 known investors

Loop Diagnostics develops an in vitro cellular immunoassay that detects sepsis within one hour of bloodstream infection, enabling early intervention through immune activity biomarker analysis. The company serves healthcare providers and aims to reduce sepsis-related mortality and disease severity through faster diagnosis than traditional pathogen identification methods.

BiotechDigital HealthMedical Devices